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Abstract: 33 
Objective: This study was performed to evaluate changes in body mass index (BMI) and 34 
health-related quality of life (HRQoL), including an acne parameter, of overweight adult 35 
women with polycystic ovary syndrome (PCOS) during a lifestyle modification program. 36 
Design: Prospective longitudinal within-patient study. 37 
Setting: Department of Reproductive Medicine of the Ghent University Hospital (Belgium). 38 
Participants: Thirty-three overweight (BMI ≥ 25 kg/m²) women with PCOS between the age 39 
of 18 and 43 years. 40 
Methods: Participants followed a 24-week lifestyle modification program, consisting of a diet, 41 
exercise, and psychological subprogram. BMI was assessed at week 0, 8, 16 and 24 of the 42 
program. The HRQoL was measured at week 0, 12 and 24 of the program using the 43 
PolyCystic Ovary Syndrome Questionnaire (PCOSQ) and a Visual Analogue Scale (VAS) 44 
evaluating the influence of acne on HRQoL.  45 
Results: Over a 24-week period no significant decrease in BMI occurred (mean difference = 46 
1.71, 95% CI [-1.38, 4.81]. During that period, there was a significant positive evolution of 47 
the total PCOSQ score (F(2,37.5) = 23.7), the emotions (F(2,37.9) = 4.2), weight (F(2,42.1) = 48 
24.8), body hair (F(2,35.6) = 3.3), and infertility problems domain scores (F(2,43.1) = 15.64) 49 
of the PCOSQ, as well as of the acne VAS score (F(2, 29.3) = 4.2). These effects primarily 50 
occurred during the first 12 weeks. 51 
Conclusion: In spite of no significant changes in BMI, the HRQoL of overweight adult 52 
women with PCOS significantly improved during a 24-week lifestyle modification program. 53 
Keywords: Polycystic ovary syndrome; overweight; life style; quality of life. 54 
Callouts 55 
‐ Overweight is a major problem in women with polycystic ovary syndrome and has a 56 
negative influence on their health-related quality of life. 57 
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‐ Our results describe a significant positive change in health-related quality of life during a 58 
24-week lifestyle modification program. 59 
‐ Overweight women with polycystic ovary syndrome should be encouraged to change their 60 
lifestyle in order to increase their health-related quality of life.  61 
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Introduction 62 
The polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of 63 
reproductive age worldwide (Broekmans et al., 2006). Overweight and obesity are present in 64 
30-70% of women with PCOS and worsen the PCOS symptom profile. More specifically, the 65 
prevalence of hirsutism, menstrual cycle irregularities, anovulation, and infertility is higher in 66 
overweight and obese women with PCOS when compared with normal weight women with 67 
PCOS (Gambineri, Pelusi, Vicennati, Pagotto, & Pasquali, 2002; Vrbikova & Hainer, 2009). 68 
Overweight in women with PCOS also has in itself as well as via the above mentioned PCOS 69 
characteristics, a negative influence on women’s health-related quality of life (HRQoL)  70 
(Jones, Hall, Balen, & Ledger, 2008). Weight loss is therefore a crucial first step in the 71 
treatment of PCOS in overweight women. A weight loss of 5-10% through lifestyle 72 
modification improves menstrual regularity, restores ovulation, and consequently increases 73 
the chance to become pregnant (Hoeger, 2006; Hoeger et al., 2004; Huber-Buchholz, Carey, 74 
& Norman, 1999; Norman, Davies, Lord, & Moran, 2002; Tang et al., 2006; Thessaloniki 75 
ESHRE/ASRM-Sponsored Consensus Workshop Group, 2008). There is also increasing 76 
evidence that lifestyle modification has a positive effect on women’s HRQoL. A 24-week 77 
randomized controlled trial in obese adolescent women with PCOS, revealed that a treatment 78 
of lifestyle modification and oral contraceptives, with or without metformin, had a positive 79 
effect on HRQoL (Harris-Glocker, Davidson, Kochman, Guzick, & Hoeger, 2010). Similarly, 80 
a 20-week lifestyle modification treatment, consisting of diet with or without exercise, had a 81 
positive impact on HRQoL in overweight and obese adult women with PCOS (Thomson et 82 
al., 2010). 83 
Evidence about the isolated effect of exercise and diet interventions on psychological 84 
well-being in women with PCOS is limited. Liao et al. (2008) found that a self-directed 85 
walking program significantly reduced the level of body image distress in overweight and 86 
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obese women with PCOS. Galletly et al. (2007) reported a lower depression rate and higher 87 
level of self-esteem after a high-protein diet when compared with a low-protein diet. To date, 88 
there is no evidence about the isolated effect of psychological interventions on the 89 
psychological well-being of women with PCOS. 90 
Notwithstanding the promising results of the Harris-Glocker et al. (2010) and 91 
Thomson et al. (2010) studies, their findings are limited in several respects. Firstly, only one 92 
of these studies focused on the effect of lifestyle modification in adult women with PCOS. 93 
Secondly, that study did not include an individual psychological subprogram in the treatment 94 
of overweight and obesity that seems to be important in weight loss programs in order to 95 
obtain a maximum effect (Shaw, O’Rourke, Del Mar, & Kenardy, 2005). Finally, neither of 96 
the two studies included an evaluation of the influence of acne on women’s HRQoL although 97 
this was reported as a limitation when studying HRQoL in women with PCOS (Jones et al., 98 
2004). Since HRQoL is an important marker from the patient’s perspective for the efficacy of 99 
a treatment (Cronin et al., 1998), additional research on this topic is needed. Accordingly, we 100 
studied changes in body mass index (BMI) and HRQoL, including an acne parameter, of 101 
overweight adult women with PCOS during a 24-week lifestyle modification program, 102 
consisting of a diet, exercise and psychological subprogram. Therefore, we hypothesized that 103 
(a) the BMI decreases and (b) the level of HRQoL increases during the 24-week LMP in 104 
overweight women with PCOS.  105 
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Methods 106 
Ethics approval 107 
This study has been reviewed and approved by the Ethics Committee of the Ghent 108 
University Hospital. Participants gave their written informed consent for participation in the 109 
study. 110 
Design, setting and participants 111 
We set up a prospective longitudinal within-patient study at the Department of 112 
Reproductive Medicine of the Ghent University Hospital (Belgium). Participants were 113 
recruited by the treating gynecologist during consultation from April 2007 till April 2009 114 
using convenience sampling. Data collection ended in October 2009. Inclusion criteria 115 
stipulated that women had to be (a) diagnosed with PCOS, (b) overweight (BMI ≥ 25 kg/m²), 116 
and (c) between the age of 18 and 43 years. PCOS was diagnosed by a gynecologist using the 117 
Rotterdam criteria (The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop 118 
group, 2004). 119 
Demographic and clinical characteristics 120 
Data on demographic and clinical characteristics were gathered by the program 121 
coordinator at the start of the LMP. Age and highest level of education (i.e., secondary or 122 
higher education) of each participant were collected during interview. Hirsutism was 123 
diagnosed by using the modified Ferriman-Gallwey (mFG) scale. The program coordinator 124 
classified the participants as hirsute when they had a mFG score ≥ 8 (Ferriman & Gallwey, 125 
1996; Yildiz, Bolour, Woods, Moore, & Azziz, 2010). The presence of facial acne was 126 
evaluated by questioning the participants if they were bothered by facial acne or not. 127 
Hyperandrogenemia was diagnosed in the presence of a free testosterone (fT) level > 0.50 128 
ng/dL, which was determined at day 2 or 3 of a spontaneous or induced menstrual cycle. 129 
  Quality of life in overweight PCOS women 
8 
 
Menstrual cycle irregularity was diagnosed when participants reported no menstrual bleeding 130 
for > 35 days (i.e., oligomenorrhea) or for > 6 months (i.e., amenorrhea). Gravidity and parity 131 
were observed as nominal variables answering the questions “Have you already been pregnant 132 
at least once?” and “Have you already given birth at least once?”, respectively. Participants 133 
were also asked whether they had a current unfulfilled wish to conceive or not.  134 
Intervention 135 
All participants followed a 24-week lifestyle modification program (LMP) consisting 136 
of a diet, exercise and psychological subprogram. Throughout the duration of the LMP, 137 
consultations with a team of professionals were planned at fixed moments in time (Table 1). 138 
Consultations with the dietician and the physiotherapist were planned at week 0, 4, 8, 16, and 139 
24 of the LMP. The frequency of the diet and exercise intervention was higher during the first 140 
part of the LMP in order to make sure that the participants adapted well to the new dietary and 141 
exercise pattern. Afterwards it was assumed that participants were informed well enough to 142 
execute the diet and exercise advice on their own for a longer period of time (Mertens, 143 
Vlayen, & Muls, 2003). The first consultation with the dietician and the physiotherapist lasted 144 
one hour and the following consultations lasted 30 minutes. Consultations with the 145 
psychologist were planned at week 0, 12, and 24 of the LMP. In addition to these fixed 146 
psychological consultations, an extra moment of psychological counseling was possible upon 147 
the demand of the participant at week 4, 8, 16, and 20 of the LMP. During these 148 
psychological counseling sessions fertility problems were mostly discussed. Each 149 
psychological consultation lasted one hour.  150 
All participants were coached individually and interventions were tailored to each 151 
participant’s degree of overweight and individual abilities. Upon participant’s wish, an 152 
important other (e.g., partner, mother) was allowed to attend all consultations. A schematic 153 
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overview with the key content components for the diet, exercise and psychological 154 
subprogram are reported in Table 2. Next, the content for each subprogram is described in 155 
detail. 156 
The diet subprogram was led by a dietician and consisted of a mild energy restricting 157 
diet (i.e., calorie restriction of 450 to 850 Kcal/day) in order to achieve an average weight loss 158 
of 0.5 kg (i.e., 1.1 lbs) per week. At the start of the program, participants were taught some 159 
general dietary principles: (1) following a daily dietary pattern of three principal meals 160 
alternated with three snacks; (2) consuming healthy food; (3) a balanced meal composition; 161 
and (4) consuming at least 1.5 L of calorie free drinks per day (e.g., water, light drinks). 162 
Additionally, all participants received personalized advice that was based on written 163 
information about a participant’s eating habit received via the use of a diet diary, on the one 164 
hand, and based on oral information about a participant’s taste preferences received during 165 
consultation, on the other hand. The diet diary was a very detailed registration of the 166 
participant’s consumed foods and drinks during three days during the week (i.e., two week 167 
days and one weekend day) (Becker-Woudstra, van Kuijeren, & Linden-Wouters, 2003). The 168 
personalized advice was supported by a list of foods and drinks that should be chosen and 169 
those that should be limited in use. 170 
The exercise subprogram was led by a physiotherapist and was focused on raising the 171 
level of physical activity during daily life. The participant’s level of physical activity was 172 
monitored during the entire duration of the LMP by counting the number of steps per day by 173 
means of a pedometer (i.e., the Yamax Digiwalker SW-200) (Crouter, Schneider, Karabulut, 174 
& Basset, 2003). This tool was used since it has been shown to be a motivational aid for 175 
increasing an individual’s physical activity level (Merom et al., 2007). During the first week 176 
of the LMP, every participant was asked to provide her total number of steps per day while 177 
performing usual daily activities in order to determine her baseline activity level. Starting 178 
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from week two of the LMP, participants started to follow up the advice of the physiotherapist. 179 
This advice consisted of suggestions on how to raise physical activity during daily life at 180 
home (e.g., going to the store on foot or with the bike instead of by car, taking the stairs 181 
instead of the elevator) and at work (e.g., taking a walk during the break in case of a sedentary 182 
job, going to your colleague instead of making a call to discuss something with her/him). 183 
Further, the physiotherapist provided concrete advice about how to practice a chosen sport. 184 
The psychological subprogram was led by a psychologist and encompassed individual 185 
cognitive behavioral therapy (CBT) (Shaw et al., 2005). Behavioral and cognitive strategies 186 
were offered for PCOS related problems (such as body image and eating behavior) and for 187 
problems associated with the LMP itself (such as motivation and stress). CBT was focused on 188 
defining and changing negative thoughts, like “Life is too busy to go to the gym” or “I can’t 189 
live without my sweets”. Other techniques consisted of problem solving strategies (“If I start 190 
eating candy, I can’t stop”), goal setting (“I will eat healthy this week”) and increasing social 191 
support (“My partner buys a lot of chocolate every week”).  192 
The program coordinator had personal or telephonic contact with each participant 193 
every two weeks to evaluate and solve problems (e.g., concerns about the progression of the 194 
LMP, rescheduling appointments) experienced by them during the LMP. 195 
Outcome measures 196 
BMI 197 
The participant’s BMI was measured at week 0, 8, 16, and 24 of the LMP by the 198 
dietician. In order to calculate the BMI (in kg/m²) participant’s body weight (in kg) and height 199 
(in m) were measured by using an electronic personal scale and a stadiometer. 200 
HRQoL 201 
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The HRQoL was assessed using the PolyCystic Ovary Syndrome Questionnaire 202 
(PCOSQ) at week 0, 12, and 24 of the LMP (Cronin et al., 1998; Guyatt, Weaver, Cronin, 203 
Dooley, & Azziz, 2004). Upon the start of the LMP, the psychologist gave basic instructions 204 
to the participants on how to fill out the PCOSQ. The PCOSQ is a disease-specific 205 
questionnaire that evaluates women’s subjective perception of the effect of specific PCOS 206 
characteristics on their quality of life. The 26-item PCOSQ consists of five domains: 207 
emotions, body hair, weight, infertility problems and menstrual problems. Each item was 208 
scored on a 7-point Likert scale (1= high concern, 7= no concern) (Cronin et al., 1998). The 209 
mean score of all domain-specific items and the mean score of the five domain scores 210 
generated the score of each PCOSQ domain and the total PCOSQ score, respectively, with 211 
higher scores indicating qualitatively higher levels of HRQoL. We retained the original time 212 
frame of two weeks for the HRQoL measurement at 12 and 24 weeks of the LMP (Cronin et 213 
al., 1998). To measure the baseline HRQoL at the start of the LMP, we used a time frame of 214 
six months. In the current study, the separate PCOSQ domain scores and the total PCOSQ 215 
score showed good reliability (Cronbach’s alpha’s ranging from .73 to .95), with the 216 
exception of the menstrual problems domain scores at the start of the LMP (Cronbach’s alpha 217 
.57) (Table 3). The construct, content, discriminant, and longitudinal validity were confirmed 218 
by prior research (Coffey, Bano, & Mason, 2006; Guyatt et al., 2004; McCook, Reame, & 219 
Tatcher, 2005). Jones et al. (2004) assessed the face validity by interviewing 12 adult women 220 
with PCOS. About 25% raised their concern about the lack of questions that addressed the 221 
influence of acne on HRQoL. Given the fact that acne is a common symptom of PCOS, this 222 
result suggested that the face validity could be improved by the addition of an acne domain to 223 
the questionnaire. Therefore, we additionally assessed to what extent the facial acne 224 
influenced participant’s HRQoL by means of a Visual Analogue Scale (VAS) (0= no 225 
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influence, 10= great influence). Contrary to the PCOSQ scores, lower VAS scores reflect a 226 
better quality of life. 227 
Statistical methods 228 
In order to test the hypothesis that (a) there is a decrease in BMI and (b) an increase in 229 
the level of HRQoL during the 24-week LMP, we analysed the evolution of the BMI, the total 230 
PCOSQ score, the five PCOSQ domain scores and the acne VAS score, separately. 231 
Linear mixed models 232 
Linear mixed model (LMM) analyses were used to account for correlated measures of 233 
the same individual at different points in time. In LMM analyses - under the assumption that 234 
missing data are random - all observations, available for a given participant, are used in the 235 
analysis (West, Welch, & Galecki, 2006), meaning that a participant with missing 236 
observations is not completely removed from the dataset (i.e., listwise deletion).  237 
To find the best fitting model, we used a top-down model building strategy (see West 238 
et al., 2006 for more details). The covariates time (weeks in program), age and education 239 
level, as well as a model-specific set of time-invariant covariates, all assessed at the start of 240 
the LMP, were included in each model. The time-invariant covariates were the BMI at the 241 
start of the program for the weight domain; the mFG score and the free testosterone level for 242 
the body hair domain; the presence of a current unfulfilled wish to conceive and the parity for 243 
the infertility problems domain; the presence of menstrual irregularity for the menstrual 244 
problems domain; and the presence of facial acne for the acne VAS. All continuous covariates 245 
were centred. Initially, each of the covariates’ interactions with the time variable was entered 246 
in the model. Non-significant interactions were removed following a backward procedure. To 247 
provide an absolute value for the goodness-of-fit, marginal and conditional R2 values were 248 
calculated for each model following the procedures described in Nakagawa & Schielzeth 249 
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(2013). Residual analyses did not reveal severe violations of the assumptions underlying the 250 
linear model. F values reported for the LMM analyses are Type III Wald F tests with 251 
Kenward-Roger degrees of freedom. 252 
Planned contrasts 253 
Once the best fitting model was found, appropriate planned contrasts between time 254 
points were examined in order to scrutinize temporal effects. The p values for each contrast 255 
were Bonferroni corrected to account for the familywise error rate due to multiple testing in 256 
each domain.  257 
Software  258 
The LMM analyses were performed using the lme4 package version 1.0-4 in R version 259 
3.0.2 (Bates, Maechler, Bolker, & Walker, 2013; R Core Team, 2013). All other statistical 260 
analyses were performed using SPSS version 21.0. The statistical significance level was set at 261 
α < .05.   262 
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Results 263 
Thirty-three study participants met the inclusion criteria. Thirty-one of them 264 
effectively participated in the study and started the LMP. Sample characteristics at the start of 265 
the LMP are reported in Table 4. In total, 8/31 (25.8%) of the included women dropped out, 266 
of which six dropped out before 12 weeks and another two after 12 weeks of the LMP. After 267 
16 weeks, no dropouts occurred. The dropout group did not differ from the remaining group 268 
in terms of demographic and clinical characteristics (all p values ≥ .05). The response rate on 269 
the PCOSQ at week 0, 12, and 24 of the LMP was 30/31 (96.8%), 22/25 (88%) and 22/23 270 
(95.7%), respectively. Seven participants used one or more extra sessions of psychological 271 
counseling.  272 
During the LMP, 13/31 (42%) participants received a fertility treatment. Three 273 
participants in the non-dropout group became pregnant during the LMP. There was no 274 
significant difference (p ≥ .05) in all outcome parameters between the pregnant and non-275 
pregnant participants at the different moments in time. 276 
Baseline PCOSQ and VAS scores 277 
At baseline, weight was of highest concern with a median domain score of 2.6 278 
[Interquartile range (IQR) = 1.85] followed by infertility problems (Mdn = 3, IQR = 1.38), 279 
menstrual problems (Mdn = 3.38, IQR = 1.63), emotions (Mdn = 4.13, IQR = 1.31) and body 280 
hair domains (Mdn = 4.8, IQR = 3.7). Although body hair was of least concern, the median 281 
body hair domain score in hirsute women was 3.1 (IQR = 2.5) when compared with 6.6 (IQR 282 
= 2.6) in non-hirsute women (p = .001). The infertility problems domain correlated 283 
significantly and positively with parity (rs = .441, p = .02). The score for this domain was also 284 
significantly different between participants with (Mdn = 2.75, IQR = 1) and without a current 285 
unfulfilled wish to conceive (Mdn = 4.25, IQR = 2, p < .001), hence reflecting a significant 286 
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higher HRQoL in the latter group. Participants educated up to secondary level reported a 287 
significant lower HRQoL on the emotions domain (Mdn = 3.5, IQR = 1.88) when comparison 288 
with higher educated participants (Mdn = 4.31, IQR = 1.16, p = .02). The weight domain was 289 
not correlated with any of the baseline characteristics and additionally, none of the PCOSQ 290 
domains were significantly correlated with the BMI measured at the start of the LMP. The 291 
median VAS score for acne was 1.1 (6.4) reflecting a low level of perceived facial acne. 292 
However, there was a significant difference in median VAS score between participants with 293 
(Mdn = 6.65, IQR = 6.98) and without facial acne (Mdn = 0.8, IQR = 1.6, p = .002). 294 
Effect of time on BMI, PCOSQ and VAS scores 295 
During the LMP, participants lost on average one kilogram per month and the mean 296 
BMI decreased from 35.49±5.96 kg/m² to 33.78±4.84 kg/m² over a period of 24 weeks (p = 297 
.27). Furthermore, between week 0 and 24, there was marginal evidence of a negative 298 
correlation between the decrease in BMI and the increase of the total PCOSQ scores (r = -.45, 299 
p = .06), the emotions domain (r = -.46, p = .05) and the body hair domain scores (r = -.41, p 300 
= .07). 301 
Next, we report the results of the LMM analyses investigating the effect of time on the 302 
total PCOSQ score, the PCOSQ domain scores and the acne VAS score separately (Table 5). 303 
We observed a significant positive effect of time on the total PCOSQ score (F(2,37.5) = 23.7, 304 
p < .001), the emotions (F(2,37.9) = 4.2, p < .05), weight (F(2,42.1) = 24.8, p < .001), body 305 
hair (F(2,35.6) = 3.3, p < .05) and infertility problems domain scores (F(2,43.1) = 15.64, p < 306 
.001) over a time period of 24 weeks. This increase was each time significant between week 0 307 
and week 12, but not between week 12 and week 24 (Table 6). With regard to the menstrual 308 
problems domain, only a marginal increase in this domain score was observed over the period 309 
of 24 weeks (F(2,38.8) = 3.08, p = .057).  310 
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The effect of time on the emotions domain scores interacted with the educational level 311 
of the participant. Over the period of 24 weeks the significant increase in emotions domain 312 
scores was less pronounced for higher educated participants (mean predicted difference = 313 
1.11, p < .001) when compared with lower educated participants (mean predicted difference = 314 
2.2, p < .001). The effect of time on the body hair domain scores interacted with the mFG 315 
score. The significant increase of the body hair domain scores during the first 12 weeks of the 316 
LMP, was only there for participants with an average or higher than average mFG score 317 
(mean predicted difference = 0.79, p < .001 and mean predicted difference = 1.32, p < .001, 318 
respectively). For participants showing lower than average mFG scores, no significant 319 
differences were observed between each of the time points. The infertility problem domain 320 
scores were influenced by the presence of a current unfulfilled wish to conceive and by the 321 
parity. The presence of a current unfulfilled wish to conceive had a negative effect (F(1, 23.1) 322 
= 21.94, p < .001) while the presence of a child had a positive effect on the PCOSQ scores 323 
(F(1, 24.4) = 4.32, p < .05). 324 
With regard to the influence of facial acne on the HRQoL, a positive evolution was 325 
observed over the 24-week period which interacted with age (F(2, 29.3) = 4.2, p < .05). The 326 
pattern of overall decrease was different for younger participants when compared with older 327 
participants. For instance, predicting average acne VAS scores for young women (using the 328 
25th percentile of age), showed a significant decrease from week 0 to week 24 and from week 329 
12 to week 24 (week 0 vs. week 24: mean predicted difference = -1.31, p < .01; week 12 vs. 330 
week 24: mean predicted difference = -0.76, p < .05). For older women (75th percentile of 331 
age), the significant decrease from week 0 to week 24 was primarily situated between week 0 332 
and week 12 (week 0 vs. week 24: mean predicted difference = -1.88, p < .001; week 0 vs. 333 
week 12: mean predicted difference  = -1.51, p < .001).  334 
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Discussion 335 
In the current study, we investigated changes in BMI and HRQoL in overweight adult 336 
women with PCOS during a 24-week LMP, consisting of a diet, exercise and psychological 337 
subprogram. Our findings point to the following conclusions: Firstly, we observed an overall 338 
increase in women’s HRQoL after 12 and 24 weeks of the LMP. This supports the findings of 339 
Harris-Glocker et al. (2010) and Thomson et al. (2010) that the HRQoL is increased at the end 340 
of a lifestyle modification period. Our findings also point to a second conclusion that the 341 
positive evolution of the HRQoL was primarily situated during the first 12 weeks of the LMP. 342 
This is in line with the study of Thomson et al. (2010) where they observed an important 343 
increase in PCOSQ domain scores during the first 10 weeks of a 20-week LMP. Despite this 344 
important increase in HRQoL during a short period of 12 weeks, it doesn’t seem justified to 345 
shorten a LMP to that time period since there is still an increase in HRQoL after 12 weeks 346 
which is possibly not at its highest level after 24 weeks of LMP. Further, a period of 24 weeks 347 
of LMP could still be too short to achieve a long-term weight reduction and maintenance 348 
according to the study of Lally, van Jaarsveld, Pott and Wardle (2010), reporting that it can 349 
take up to 254 days to form a new habit. Additional research on this issue is therefore needed.  350 
Furthermore, our results confirm that body weight, irrespective of the BMI, is a high 351 
concern in women with PCOS (Coffey et al., 2006; Vrbikova & Hainer, 2009). In addition, 352 
over the period of 24 weeks, there was a decrease of 5% in BMI and a trend towards a 353 
correlation between the decrease in BMI and the increase in HRQoL. This confirms the 354 
findings of Harris-Glocker et al. (2010) who observed a trend towards a correlation between 355 
the decrease in BMI and the increase in PCOSQ weight domain scores over a period of 24 356 
weeks in a group of obese adolescent women with PCOS (r = -.333, p = .06). A similar 357 
correlation was found by Thomson et al. (2010) for the emotions and weight domain scores (r 358 
= -.35 and r = -.43, p ≤ .01, respectively) in overweight and obese adult women with PCOS. 359 
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These results suggest that a modest weight loss is sufficient to elicit an increase in HRQoL, in 360 
addition to its positive effects observed with respect to the endocrine and metabolic features 361 
of PCOS (Hoeger et al., 2004; Thomson et al., 2008).  362 
In our study, the presence of visible hair growth appeared to be the least concern when 363 
compared with the other PCOSQ domains at the start of the LMP. We also observed a 364 
significant negative correlation between the presence of hirsutism and HRQoL similar to 365 
earlier findings by Harris-Glocker et al. (2010) and Mc Cook et al. (2005). There is evidence 366 
that lifestyle treatment leads to an amelioration of hirsutism (Moran, Hutchinson, Norman, & 367 
Teede, 2011), however, as the life span of hair follicles is six months, the effect of LMP on 368 
the presence of hirsutism can be adequately assessed only after this time period (Castelo-369 
Branco & Cancelo, 2010). Interestingly, we observed a positive evolution of the body hair 370 
domain scores over the whole study period. This cannot be confirmed by the study of 371 
Thomson et al. (2010), where no significant evolution in body hair domain scores was 372 
observed over the 20-week study period. In our study, the increase in body hair domain scores 373 
was significant during the first 12 weeks of LMP, followed by a decrease during the second 374 
half of the program. 375 
Since acne is also a clinical sign of hyperandrogenism, some studies have highlighted 376 
the necessity to include the presence of visible acne in the evaluation of the HRQoL of 377 
women with PCOS (Harris-Glocker et al., 2010; Jones et al., 2004). Consequently, we 378 
assessed the influence of visible facial acne on the HRQoL of the participants. Indeed, we 379 
observed a significant improvement of the influence of acne on the HRQoL during the total 380 
length of the LMP. Our findings thereby underscore the importance of including acne as an 381 
additional indicator of treatment efficacy for HRQoL outcomes. In the future, an acne domain 382 
should be included in the PCOSQ and this modified version of the PCOSQ should be 383 
validated in a group of adolescent and adult women with PCOS. 384 
  Quality of life in overweight PCOS women 
19 
 
A study by Elsenbruch et al. (2006) described that the level of education, among other 385 
parameters, is an important determinant of emotional distress in women with PCOS. Hence, 386 
we took this into account while performing all our analyses. Indeed, we observed a lower 387 
PCOSQ emotions domain score in secondary educated study participants at the start of the 388 
LMP. Also, the level of education had a significant influence on the effect of time on the 389 
PCOSQ emotions domain score.  390 
Fertility problems are an important consequence of PCOS, especially in overweight 391 
women (Vrbikova & Hainer, 2009). In our study, 71% of the participants had an unfulfilled 392 
wish to conceive and 77% had never given birth at the start of the LMP. Forty-two percent 393 
had a fertility treatment during the LMP. Since McCook et al. (2005) describes that the 394 
delivery of a viable child has a significant impact on the infertility problems domain score of 395 
the PCOSQ, we adjusted the analyses of that domain for the variable parity. Additionally, we 396 
took the objective evaluation of the presence of a current unfulfilled wish to conceive into 397 
account as the PCOSQ infertility problems domain looks into the participant’s subjective 398 
perception of fertility problems (Cronin et al., 1998). Three participants became pregnant 399 
during the LMP but that didn’t affect the outcome measures. 400 
Strengths and limitations 401 
We used a prospective longitudinal within-subject design creating the possibility to 402 
study the effect of time at different moments in time and having the advantage to minimize 403 
the recall error (Polit & Beck, 2004). On the contrary, this had the disadvantage of inducing 404 
the Hawthorne effect (Polit & Beck, 2004). The fact that women knew they were under study 405 
could possibly have influenced the way they felt, as well as the way they answered the 406 
questionnaire. Psychological therapy (i.e., CBT) was described by Shaw et al. (2005) to be 407 
important in weight loss programs in order to obtain a maximum effect, and it was therefore 408 
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included in our LMP. However, the design of the current study did not allow to test the 409 
additional value of this subprogram to the LMP. Neither it was possible to evaluate the benefit 410 
of the other two components of this LMP (i.e., the diet and exercise subprogram). Therefore 411 
future research using a randomized controlled study design is needed. 412 
We also have to acknowledge the small sample size of 31 women with PCOS and a 413 
large number of missing data at different moments in time. This was due to women who 414 
failed to complete the questionnaire, and due to women who dropped out during the LMP. 415 
This missing information resulted in an unbalanced data set. This limitation was partly 416 
accounted for by using a LMM analysis (Verbeke & Molenberghs, 2000; West et al., 2006). 417 
The small sample size might also be a reason for low Cronbach’s alpha scores of the PCOSQ 418 
(Rouquette & Falissard, 2011). 419 
The drop-out rate in our study was 25.8% which is much lower than the drop-out rate 420 
during the 20-week LMP performed by Thomson et al. (2010) (i.e., 55.32%). It is described 421 
that the risk of attrition is especially large when the length of time between points of data 422 
collection is long (Polit & Beck, 2004). Interestingly, in our study most drop-outs occurred 423 
during the first part of LMP although the time between the consultations was longer when the 424 
program progressed. On the other hand, this is in line with the Iannaccone et al. (2013) study 425 
which reports that the risk of attrition is especially large during the beginning of longitudinal 426 
studies. A study by Galletly et al. (2007) mentions that a better compliance is possibly related 427 
to better feelings of psychological well-being. This might have been an influencing factor for 428 
drop-out but we have not registered the reason for drop-out due to lack of follow-up data. 429 
Implications for Practice 430 
Several health professionals play an important role in treating and counseling 431 
overweight women with PCOS (i.a., physicians, nurses and midwives, psychologists). Based 432 
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on results of our study, it is clear that HRQoL in overweight women with PCOS evolves 433 
positively during a 24-week LMP. Additionally, earlier research described the positive effect 434 
of lifestyle modification on physical parameters in women with PCOS (Hoeger, 2006; Hoeger 435 
et al., 2004; Huber-Buchholz et al., 1999; Norman et al., 2002; Tang et al., 2006; Thessaloniki 436 
ESHRE/ASRM-Sponsored Consensus Workshop Group, 2008). Nurses and midwives who 437 
come into contact with those women should be aware of this existing evidence and, 438 
consequently, they should inform women about the benefits of lifestyle modification in terms 439 
of HRQoL. Nurses and midwives could contribute to the provision of adequate care to women 440 
with PCOS by referring them to the professionals whom are part of a multidisciplinary 441 
lifestyle modification team (i.e., physician, physiotherapist, dietician, psychologist). 442 
Furthermore, nurses and midwives may also play an active role by coordinating a LMP, 443 
encouraging women to participate in a LMP, and by supporting them to maintain a modified 444 
lifestyle. 445 
Recommendations for Future Research 446 
To determine if a psychological subprogram has an additional benefit to a LMP, a 447 
randomized controlled trial should be performed. In addition, a long term cost-effectiveness 448 
analysis is needed to make a decision about the acceptable length of LMPs in terms of weight 449 
reduction, weight maintenance, and HRQoL in overweight women with PCOS. 450 
Conclusion 451 
In summary, our findings indicate that the HRQoL of overweight adult women with 452 
PCOS evolved positively, especially during the first 12 weeks of a 24-week LMP, consisting 453 
of a diet, exercise and psychological subprogram. Based on these results as well as on the 454 
results of the study of Thomson et al. (2010), overweight adult women with PCOS should be 455 
encouraged to follow a lifestyle modification program in order to increase their HRQoL. 456 
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Table 1. 
Schedule of consultation with the appropriate professional per subprogram during the 24-
week lifestyle modification program (LMP) 
  Week of LMP 
Subprogram 0 2 4 6 8 10 12 14 16 18 20 22 24 
Diet subprogram * * * * * 
Exercise subprogram * * * * * 
Psychological subprogram *   (*)   (*)   *   (*)   (*)   * 
Note. (*) = extra consultation on demand of the participant. 
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Table 2. 
Key content components for the diet, exercise and psychological subprogram 
Subprogram Key content components 
Diet subprogram Mild energy restriction (i.e., -450 to -850 Kcal/day) 
 General dietary principles 
      Daily dietary pattern of three principal meals alternated with three snacks 
      Healthy food 
      Balanced meal composition 
      ≥ 1.5 L of calorie free drinks per day 
Exercise subprogram Raising daily physical activity level through increasing number of steps per day 
 Practicing sports 
Psychological subprogram Cognitive behavioral therapy 
 Additional techniques: 
      Problem solving 
      Goal setting 
      Increasing social support 
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Table 3. 
Psychometric properties of the PolyCystic Ovary Syndrome Questionnaire (PCOSQ) and 
the acne Visual Analogue Scale (VAS) 
    week 0  week 12  week 24 
PCOSQ Cronbach’s alpha coefficient 
Five domains 
     Emotions .74 .86 .84 
     Weight .83 .84 .93 
     Body hair .94 .95 .94 
     Infertility problems .73 .81 .92 
     Menstrual problems .57 .74 .80 
Total PCOSQ .40 .65 .81 
VAS Mdn IQR Mdn IQR Mdn IQR 
     Acne problems 1.1 6.4 0.9 2.38 0.2 1.5 
Note. IQR = interquartile range; Mdn = Median 
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Table 4. 
Demographic and clinical characteristics of the participants at the start of the lifestyle modification 
program 
Characteristic n Mdn IQR Frequency % 
Demographic characteristic 
Age in years 31 29 5 
Highest level of education 
     Secondary education 29 7 24 
     Higher education 29 22 76 
Clinical characteristic 
Gravidity 31 9 29 
Parity 31 7 23 
Current unfulfilled wish to conceive 31 22 71 
Duration of unfulfilled wish to conceive in days 31 731 944 
Body mass index in kg/m² 31 33.74 7.8 
Irregular menstrual cycle 31 29 94 
Presence of hirsutism 30 13 43 
Presence of facial acne 31 15 48 
Free testosterone in ng/dL 31 0.82 0.95 
Note. Mdn = Median, IQR = interquartile range. Gravidity = number of women who had been pregnant at 
least once, Parity = number of women who had given birth at least once. 
Continuous measurements are summarized as Median (IQR) since they are not symmetrically distributed.
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Table 5.  
Fixed effects and their interactions for all models from the linear mixed effects analysis using restricted 
maximum likelihood estimation 
Dependent variable Predictor b SE(b) t 
PCOSQ domain 
     Emotions Intercept 4.40 0.23 19.50 
Time (week 12) 0.82 0.23 3.55 
Time (week 24) 1.11 0.24 4.63 
Age in years -0.01 0.03 -0.35 
Secondary education (yes) -1.06 0.45 -2.34 
Time x Education 
     Time (week 12) x Secondary education (yes) 1.33 0.50 2.67 
     Time (week 24) x Secondary education (yes) 1.08 0.50 2.15 
          R²glmm(m) = 31.79% 
          R²glmm(c) = 71.25% 
     Weight Intercept 2.45 0.25 9.76 
Time (week 12) 1.51 0.27 5.61 
Time (week 24) 1.75 0.27 6.37 
Age in years -0.02 0.03 -0.71 
Secondary education (yes) 0.51 0.45 1.13 
Body mass index in kg/m² -0.07 0.04 -1.86 
          R²glmm(m) = 35.32%  
          R²glmm(c) = 63.18%  
     Body hair Intercept 4.79 0.33 14.59 
Time (week 12) 0.79 0.20 3.93 
Time (week 24) 0.53 0.20 2.62 
Age in years -0.02 0.05 -0.43 
Secondary education (yes) -0.09 0.65 -0.13 
mFG score -0.19 0.04 -4.42 
Free testosterone level in ng/dL 0.12 0.18 0.67 
Time x mFG score 
     Time (week 12) x mFG score 0.08 0.03 2.58 
     Time (week 24) x mFG score 0.03 0.04 0.79 
          R²glmm(m) = 36.03%  
          R²glmm(c) = 87.59%  
     Infertility problems Intercept 4.09 0.35 11.81 
Time (week 12) 1.29 0.30 4.28 
Time (week 24) 1.57 0.31 5.11 
Age in years 0.01 0.03 0.32 
Secondary education (yes) 0.32 0.37 0.86 
Current unfulfilled wish to conceive (present) -1.56 0.33 -4.71 
Parity (yes) 0.97 0.46 2.10 
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          R²glmm(m) = 52.66%  
          R²glmm(c) = 59.82%  
     Menstrual problems Intercept 5.61 1.07 5.26 
Time (week 12) 0.55 0.29 1.88 
Time (week 24) 0.68 0.30 2.30 
Age in years -0.01 0.05 -0.25 
Secondary education (yes) -0.76 0.61 -1.24 
Menstrual cycle irregularity (present) -1.77 1.04 -1.70 
          R²glmm(m) = 14.19%  
          R²glmm(c) = 65.29%  
Total PCOSQ Intercept 3.72 0.20 18.79 
Time (week 12) 1.00 0.18 5.42 
Time (week 24) 1.19 0.19 6.22 
Age in years 0.001 0.03 0.03 
Secondary education (yes)  0.05 0.37 0.14 
          R²glmm(m) = 25.91% 
          R²glmm(c) = 69.65% 
Acne VAS 
     Acne problems Intercept 1.13 0.59 1.92 
Time (week 12) -0.32 0.40 -0.80 
Time (week 24) -0.73 0.55 -1.34 
Age in years 0.08 0.08 0.96 
Secondary education (yes) -0.79 0.74 -1.07 
Acne (present) 4.27 0.91 4.69 
Time x Age 
     Time (week 12) x Age in years -0.19 0.07 -2.96 
     Time (week 24) x Age in years -0.12 0.08 -1.52 
Time x Acne 
     Time (week 12) x Acne (present) -1.51 0.64 -2.36 
     Time (week 24) x Acne (present) -1.77 0.84 -2.11 
          R²glmm(m) = 27.65% 
          R²glmm(c) = 93.08% 
          
Note. Parity was observed as a nominal variable answering the question "Have you already been 
pregnant at least once?". PCOSQ = PolyCystic Ovary Syndrome Questionnaire; mFG =  modified 
Ferriman-Gallwey; VAS = Visual Analogue Scale. R²glmm(m) = marginal R² (i.e., variance explained by 
fixed factors); R²glmm(c) = conditional R² (i.e., variance explained by the entire model) (Nakagawa & 
Schielzeth, 2013). 
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Table 6. 
Mean predicted score per PCOSQ domain and mean predicted acne VAS score at the start, and mean differences at 12 and 24 weeks of the 
lifestyle modification program 
    week 0  week 0 vs. week 12  week 12 vs. week 24  week 0 vs. week 24 
Dependent variable      Mean difference 95% CI  Mean difference 95% CI  Mean difference 95% CI 
PCOSQ domain 
Emotions 4.13 1.48** [0.99, 1.97] 0.17 [-0.37, 0.71] 1.66** [1.16, 2.15] 
Weight 2.61 1.51** [0.98, 2.04] 0.24 [-0.33, 0.80] 1.75** [1.21, 2.28] 
Body hair 4.86 0.79** [0.40, 1.18] -0.25 [-0.67, 0.16] 0.53* [0.14, 0.93] 
Infertility problems 3.31 1.29** [0.70, 1.88] 0.28 [-0.37, 0.92] 1.57** [0.97, 2.17] 
Menstrual problems 3.80 0.55 [-0.02, 1.12] 0.14 [-0.48, 0.75] 0.68 [0.09, 1.26] 
Total PCOSQ 3.38 1.00** [0.64, 1.36] 0.18 [-0.21, 0.58] 1.18** [0.81, 1.56] 
Acne VAS 
Acne problems   2.60  -1.08** [-1.70, 0.45]  -0.55 [-1.20, 0.11]  -1.62** [-2.45, -0.80] 
Note. Mean predicted outcome scores are calculated with typical values of the explanatory variables in each model (Fox, 2003). PCOSQ = 
PolyCystic Ovary Syndrome Questionnaire; VAS = Visual Analogue Scale; CI = confidence interval. 
** p < .01. * p < .05 (Bonferroni corrected for multiple testing per domain). 
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